Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

NCT00967655 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: capecitabine
DRUG: irinotecan hydrochloride
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery
RADIATION: radiation therapy

Sponsor

Loma Linda Oncology Medical Group, Inc.